Nothing Special   »   [go: up one dir, main page]

GB1336609A - Antismoking preparation - Google Patents

Antismoking preparation

Info

Publication number
GB1336609A
GB1336609A GB5989471A GB1336609DA GB1336609A GB 1336609 A GB1336609 A GB 1336609A GB 5989471 A GB5989471 A GB 5989471A GB 1336609D A GB1336609D A GB 1336609DA GB 1336609 A GB1336609 A GB 1336609A
Authority
GB
United Kingdom
Prior art keywords
silver
preparations
compound
smoking
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5989471A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB1336609A publication Critical patent/GB1336609A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23GCOCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00Chewing gum
    • A23G4/06Chewing gum characterised by the composition containing organic or inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058Chewing gums

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Confectionery (AREA)

Abstract

1336609 Anti-smoking preparations D C WOODCRAFT 26 Sept 1972 [23 Dec 1971] 59894/71 Heading A5B Orally acceptable anti-smoking preparations comprise a silver amine complex or a silver compound and an ammonium compound which in the dissolved state combines with silver to form silver diamine complex ions. Preferred compositions comprise a silver salt such as silver lactate or silver acetate and sufficient ammonium nitrate to convert all the silver to silver diamine complex, but silver salts plus thiosulphates may also be used. The preparations may be in conventional solid and liquid forms, e.g. a tablet, solution or aerosol preparation, and may optionally comprise a co-carboxylase.
GB5989471A 1971-12-23 1972-09-26 Antismoking preparation Expired GB1336609A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5989471 1971-12-23

Publications (1)

Publication Number Publication Date
GB1336609A true GB1336609A (en) 1973-11-07

Family

ID=10484601

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5989471A Expired GB1336609A (en) 1971-12-23 1972-09-26 Antismoking preparation

Country Status (12)

Country Link
JP (1) JPS4885722A (en)
AU (1) AU5010472A (en)
BR (1) BR7208979D0 (en)
DE (1) DE2262497A1 (en)
DK (1) DK131892C (en)
FI (1) FI51049C (en)
GB (1) GB1336609A (en)
IE (1) IE38113B1 (en)
IL (1) IL40366A0 (en)
MT (1) MTP728B (en)
NL (1) NL7217411A (en)
ZA (1) ZA726026B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2180156A (en) * 1985-09-10 1987-03-25 Besco Lab Inc Sprayable oral composition to prevent smoking
EP1153616A1 (en) * 1999-02-15 2001-11-14 Sumitomo Pharmaceuticals Company, Limited Tablets quickly disintegrated in the oral cavity
GB2362571A (en) * 2000-03-14 2001-11-28 Azn Biotech Ltd Compositions for curbing smoking

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3730522B2 (en) 2000-07-21 2006-01-05 太陽化学株式会社 Smoking craving suppression composition

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2180156A (en) * 1985-09-10 1987-03-25 Besco Lab Inc Sprayable oral composition to prevent smoking
GB2180156B (en) * 1985-09-10 1989-10-11 Besco Lab Inc Sprayable composition to prevent smoking
EP1153616A1 (en) * 1999-02-15 2001-11-14 Sumitomo Pharmaceuticals Company, Limited Tablets quickly disintegrated in the oral cavity
EP1153616A4 (en) * 1999-02-15 2003-04-02 Sumitomo Pharma Tablets quickly disintegrated in the oral cavity
GB2362571A (en) * 2000-03-14 2001-11-28 Azn Biotech Ltd Compositions for curbing smoking

Also Published As

Publication number Publication date
IL40366A0 (en) 1972-11-28
MTP728B (en) 1973-02-15
DK131892B (en) 1975-09-22
IE38113L (en) 1973-06-23
FI51049B (en) 1976-06-30
DK131892C (en) 1976-02-16
FI51049C (en) 1976-10-11
NL7217411A (en) 1973-06-26
IE38113B1 (en) 1978-01-04
JPS4885722A (en) 1973-11-13
DE2262497A1 (en) 1973-07-05
AU5010472A (en) 1974-06-20
BR7208979D0 (en) 1973-09-20
ZA726026B (en) 1973-05-30

Similar Documents

Publication Publication Date Title
IE32758L (en) Propanolamine derivatives
CA973554A (en) 2,3,5,6-tetraaminopyridine and its acid salts and processes for its preparation
GB1167993A (en) Novel Chemical Compounds, Process for Making Same and Method of Treatment
AU468994B2 (en) 2,3-DIHYDRO-OXOIMIDAZO [1,2-a] PYRIMIDINES, THEIR ACID ADDITION SALTS THEREOF AND PROCESSES FOR THEIR PREPARATION
IE38641L (en) Pyrazolodiazepine compounds
GB1336609A (en) Antismoking preparation
IE35376L (en) Pyrimidine derivatives
CA936533A (en) 5-aryl-2,3-dihydro-2,2(or 3,3) dimethyl-5h-imidazo(2,1-a) isoindol-5-ols and 2(4,4(5,5) dimethyl-2-imidazolin-2-yl) bensophenone acid addition salts and processes for their preparation
GB1362845A (en) Benzyl alcohol derivatives
GB1336610A (en) Antismoking chewing gum preparation
IE34609B1 (en) Antineoplastic therapeutic compositions
IE35507L (en) Preparations containing tetrahydrocarbazole¹derivatives
GB1508601A (en) Oxytetracycline solution
AU473287B2 (en) Substituted phenllimida zolidinones, the acid addition salts thereof and processes for their preparation
GB1364366A (en) Derivatives of 4-chloro-5-sulphamoyl-anthranilic acid their preparation and pahamaceutical compositions comprising them
ZA715813B (en) Improvements relating to 1,2,3,6-tetrahydro-4-pyridylmethyl-carbonic acid esters,as well as the acid addition salts and quaternary ammonium compounds thereof
IE33519B1 (en) Novel benzyl-hydrazide derivatives and a process for the manufacture thereof and novel benzylidene-hydrazide derivatives useful in said process
GB1263206A (en) Complexes and salts of magnesium with orotic acid and amino acids
GB1148758A (en) Substituted ªÐ-aminobenzamides, their preparation and use
IE33581L (en) Compositions comprising l-dopa
GB1153471A (en) Antiprotozoal 8-Aminoquinoline Derivatives
GB1266430A (en)
GB1291325A (en) Silver ammine fluoride solution and method of its use
GB1349207A (en) Pharmaceutical compositions
IE32211L (en) Therapeutic compositions

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee